New

Brain Metastasis Therapeutic Market

2021

Brain Metastasis Therapeutic Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Treatment (Corticosteroids, Anticonvulsants, Targeted Therapy, Chemotherapy, Radiation Therapy); End-user (Cancer Research Centers, Cancer Hospitals, Clinics, Others) and Geography

| Report Code: TIPRE00024321 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Brain Metastasis Therapeutic Market 2028 By Treatment, End-user and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Brain metastasis is a type of cancer caused when cancer cells spread from their original site to the brain. This may result in mortality and morbidity among cancer patients. Generally, cancer that spreads to the brain includes lung cancer, breast cancer, melanoma, renal cell carcinoma, and others. Cancers are commonly present in the brain cerebrum. As the metastatic brain tumors progress and create pressure and change the function of surrounding brain tissues, it gives rise to various symptoms, including edema, seizure, headache, personality changes, memory loss, and many more.

MARKET SCOPE

The "Global Brain Metastasis Therapeutic Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the brain metastasis therapeutic market with detailed market segmentation by treatment, end user, and geography. The report provides key statistics on the market status of the leading brain metastasis therapeutic market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on treatment, the global brain metastasis therapeutic market is segmented into corticosteroids, anticonvulsants, targeted therapy, chemotherapy and radiation therapy.
  •  On the basis of end-users, the market is bifurcated into cancer research centers, cancer hospitals, clinics and others.

MARKET DYNAMICS
Drivers:

  •  Increase in the number of brain cancer cases.
  •  Increase in need for treatment for symptoms associated with brain metastasis.
  •  Growing R&D activities for drug improvement.

Restraints:

  •  High cost of treatment.
  •  Side effects associated with the chemotherapy.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The brain metastasis therapeutic market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the brain metastasis therapeutic market in these regions.

IMPACT OF COVID-19ON BRAIN METASTASIS THERAPEUTIC MARKET

COVID-19 initially began in Wuhan (China) in December 2019, and till now, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The pandemic has been affecting economies and industries in different countries due to travel bans, lockdowns, and business shutdowns. The shutdown of various plants and factories affected the worldwide supply chains and negatively impacted the brain metastasis therapeutics market's manufacturing activities, delayed delivery schedules, and affected sales. Thus, owing to the factors mentioned above, market growth was impacted during the pandemic.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the brain metastasis therapeutic market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from brain metastasis therapeutic market are anticipated to have lucrative growth opportunities in the future with the rising demand for brain metastasis therapeutic in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the brain metastasis therapeutic market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  F. Hoffmann-La Roche Ltd.
  •  Sanofi
  •  AstraZeneca
  •  GlaxoSmithKline
  •  Eli Lilly & Company
  •  AngioChem Inc.
  •  Merck & Co., Inc.
  •  Bayer AG
  •  Novartis AG
  •  Pfizer Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Brain Metastasis Therapeutic Market - By Treatment
1.3.2 Brain Metastasis Therapeutic Market - By End-user
1.3.3 Brain Metastasis Therapeutic Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. BRAIN METASTASIS THERAPEUTIC MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. BRAIN METASTASIS THERAPEUTIC MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. BRAIN METASTASIS THERAPEUTIC MARKET - GLOBAL MARKET ANALYSIS
6.1. BRAIN METASTASIS THERAPEUTIC - GLOBAL MARKET OVERVIEW
6.2. BRAIN METASTASIS THERAPEUTIC - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING

7. BRAIN METASTASIS THERAPEUTIC MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT
7.1. OVERVIEW
7.2. TREATMENT MARKET FORECASTS AND ANALYSIS
7.3. CORTICOSTEROIDS
7.3.1. Overview
7.3.2. Corticosteroids Market Forecast and Analysis
7.4. ANTICONVULSANTS
7.4.1. Overview
7.4.2. Anticonvulsants Market Forecast and Analysis
7.5. TARGETED THERAPY
7.5.1. Overview
7.5.2. Targeted Therapy Market Forecast and Analysis
7.6. CHEMOTHERAPY
7.6.1. Overview
7.6.2. Chemotherapy Market Forecast and Analysis
7.7. RADIATION THERAPY
7.7.1. Overview
7.7.2. Radiation Therapy Market Forecast and Analysis
8. BRAIN METASTASIS THERAPEUTIC MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
8.1. OVERVIEW
8.2. END-USER MARKET FORECASTS AND ANALYSIS
8.3. CANCER RESEARCH CENTERS
8.3.1. Overview
8.3.2. Cancer Research Centers Market Forecast and Analysis
8.4. CANCER HOSPITALS
8.4.1. Overview
8.4.2. Cancer Hospitals Market Forecast and Analysis
8.5. CLINICS
8.5.1. Overview
8.5.2. Clinics Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis

9. BRAIN METASTASIS THERAPEUTIC MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Brain Metastasis Therapeutic Market Overview
9.1.2 North America Brain Metastasis Therapeutic Market Forecasts and Analysis
9.1.3 North America Brain Metastasis Therapeutic Market Forecasts and Analysis - By Treatment
9.1.4 North America Brain Metastasis Therapeutic Market Forecasts and Analysis - By End-user
9.1.5 North America Brain Metastasis Therapeutic Market Forecasts and Analysis - By Countries
9.1.5.1 United States Brain Metastasis Therapeutic Market
9.1.5.1.1 United States Brain Metastasis Therapeutic Market by Treatment
9.1.5.1.2 United States Brain Metastasis Therapeutic Market by End-user
9.1.5.2 Canada Brain Metastasis Therapeutic Market
9.1.5.2.1 Canada Brain Metastasis Therapeutic Market by Treatment
9.1.5.2.2 Canada Brain Metastasis Therapeutic Market by End-user
9.1.5.3 Mexico Brain Metastasis Therapeutic Market
9.1.5.3.1 Mexico Brain Metastasis Therapeutic Market by Treatment
9.1.5.3.2 Mexico Brain Metastasis Therapeutic Market by End-user
9.2. EUROPE
9.2.1 Europe Brain Metastasis Therapeutic Market Overview
9.2.2 Europe Brain Metastasis Therapeutic Market Forecasts and Analysis
9.2.3 Europe Brain Metastasis Therapeutic Market Forecasts and Analysis - By Treatment
9.2.4 Europe Brain Metastasis Therapeutic Market Forecasts and Analysis - By End-user
9.2.5 Europe Brain Metastasis Therapeutic Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Brain Metastasis Therapeutic Market
9.2.5.1.1 Germany Brain Metastasis Therapeutic Market by Treatment
9.2.5.1.2 Germany Brain Metastasis Therapeutic Market by End-user
9.2.5.2 France Brain Metastasis Therapeutic Market
9.2.5.2.1 France Brain Metastasis Therapeutic Market by Treatment
9.2.5.2.2 France Brain Metastasis Therapeutic Market by End-user
9.2.5.3 Italy Brain Metastasis Therapeutic Market
9.2.5.3.1 Italy Brain Metastasis Therapeutic Market by Treatment
9.2.5.3.2 Italy Brain Metastasis Therapeutic Market by End-user
9.2.5.4 Spain Brain Metastasis Therapeutic Market
9.2.5.4.1 Spain Brain Metastasis Therapeutic Market by Treatment
9.2.5.4.2 Spain Brain Metastasis Therapeutic Market by End-user
9.2.5.5 United Kingdom Brain Metastasis Therapeutic Market
9.2.5.5.1 United Kingdom Brain Metastasis Therapeutic Market by Treatment
9.2.5.5.2 United Kingdom Brain Metastasis Therapeutic Market by End-user
9.2.5.6 Rest of Europe Brain Metastasis Therapeutic Market
9.2.5.6.1 Rest of Europe Brain Metastasis Therapeutic Market by Treatment
9.2.5.6.2 Rest of Europe Brain Metastasis Therapeutic Market by End-user
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Brain Metastasis Therapeutic Market Overview
9.3.2 Asia-Pacific Brain Metastasis Therapeutic Market Forecasts and Analysis
9.3.3 Asia-Pacific Brain Metastasis Therapeutic Market Forecasts and Analysis - By Treatment
9.3.4 Asia-Pacific Brain Metastasis Therapeutic Market Forecasts and Analysis - By End-user
9.3.5 Asia-Pacific Brain Metastasis Therapeutic Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Brain Metastasis Therapeutic Market
9.3.5.1.1 Australia Brain Metastasis Therapeutic Market by Treatment
9.3.5.1.2 Australia Brain Metastasis Therapeutic Market by End-user
9.3.5.2 China Brain Metastasis Therapeutic Market
9.3.5.2.1 China Brain Metastasis Therapeutic Market by Treatment
9.3.5.2.2 China Brain Metastasis Therapeutic Market by End-user
9.3.5.3 India Brain Metastasis Therapeutic Market
9.3.5.3.1 India Brain Metastasis Therapeutic Market by Treatment
9.3.5.3.2 India Brain Metastasis Therapeutic Market by End-user
9.3.5.4 Japan Brain Metastasis Therapeutic Market
9.3.5.4.1 Japan Brain Metastasis Therapeutic Market by Treatment
9.3.5.4.2 Japan Brain Metastasis Therapeutic Market by End-user
9.3.5.5 South Korea Brain Metastasis Therapeutic Market
9.3.5.5.1 South Korea Brain Metastasis Therapeutic Market by Treatment
9.3.5.5.2 South Korea Brain Metastasis Therapeutic Market by End-user
9.3.5.6 Rest of Asia-Pacific Brain Metastasis Therapeutic Market
9.3.5.6.1 Rest of Asia-Pacific Brain Metastasis Therapeutic Market by Treatment
9.3.5.6.2 Rest of Asia-Pacific Brain Metastasis Therapeutic Market by End-user
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Brain Metastasis Therapeutic Market Overview
9.4.2 Middle East and Africa Brain Metastasis Therapeutic Market Forecasts and Analysis
9.4.3 Middle East and Africa Brain Metastasis Therapeutic Market Forecasts and Analysis - By Treatment
9.4.4 Middle East and Africa Brain Metastasis Therapeutic Market Forecasts and Analysis - By End-user
9.4.5 Middle East and Africa Brain Metastasis Therapeutic Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Brain Metastasis Therapeutic Market
9.4.5.1.1 South Africa Brain Metastasis Therapeutic Market by Treatment
9.4.5.1.2 South Africa Brain Metastasis Therapeutic Market by End-user
9.4.5.2 Saudi Arabia Brain Metastasis Therapeutic Market
9.4.5.2.1 Saudi Arabia Brain Metastasis Therapeutic Market by Treatment
9.4.5.2.2 Saudi Arabia Brain Metastasis Therapeutic Market by End-user
9.4.5.3 U.A.E Brain Metastasis Therapeutic Market
9.4.5.3.1 U.A.E Brain Metastasis Therapeutic Market by Treatment
9.4.5.3.2 U.A.E Brain Metastasis Therapeutic Market by End-user
9.4.5.4 Rest of Middle East and Africa Brain Metastasis Therapeutic Market
9.4.5.4.1 Rest of Middle East and Africa Brain Metastasis Therapeutic Market by Treatment
9.4.5.4.2 Rest of Middle East and Africa Brain Metastasis Therapeutic Market by End-user
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Brain Metastasis Therapeutic Market Overview
9.5.2 South and Central America Brain Metastasis Therapeutic Market Forecasts and Analysis
9.5.3 South and Central America Brain Metastasis Therapeutic Market Forecasts and Analysis - By Treatment
9.5.4 South and Central America Brain Metastasis Therapeutic Market Forecasts and Analysis - By End-user
9.5.5 South and Central America Brain Metastasis Therapeutic Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Brain Metastasis Therapeutic Market
9.5.5.1.1 Brazil Brain Metastasis Therapeutic Market by Treatment
9.5.5.1.2 Brazil Brain Metastasis Therapeutic Market by End-user
9.5.5.2 Argentina Brain Metastasis Therapeutic Market
9.5.5.2.1 Argentina Brain Metastasis Therapeutic Market by Treatment
9.5.5.2.2 Argentina Brain Metastasis Therapeutic Market by End-user
9.5.5.3 Rest of South and Central America Brain Metastasis Therapeutic Market
9.5.5.3.1 Rest of South and Central America Brain Metastasis Therapeutic Market by Treatment
9.5.5.3.2 Rest of South and Central America Brain Metastasis Therapeutic Market by End-user

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. BRAIN METASTASIS THERAPEUTIC MARKET, KEY COMPANY PROFILES
11.1. F. HOFFMANN-LA ROCHE LTD.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. SANOFI
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ASTRAZENECA
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GLAXOSMITHKLINE
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ELI LILLY AND COMPANY
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ANGIOCHEM INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MERCK AND CO., INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. BAYER AG
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. NOVARTIS AG
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. PFIZER INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. F. Hoffmann-La Roche Ltd.
2. Sanofi
3. AstraZeneca
4. GlaxoSmithKline
5. Eli Lilly and Company
6. AngioChem Inc.
7. Merck and Co., Inc.
8. Bayer AG
9. Novartis AG
10. Pfizer Inc.
TIPRE00024321
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.